npj Breast Cancer (editorial office), 2026-06-05: Editorial Expression of Concern stating that the publisher found multiple highly similar images in Fig. 4d and 4f of the 2021 ivermectin/anti-PD1 paper, that the authors said the original data are no longer available, and that readers should interpret the data with caution.
The Editor would like to alert the readers that concerns have been raised regarding multiple highly similar images between Fig. 4d and f. The authors issued a Correction to exclude some of the duplicate data; however, further checks by the Publisher found further similarities.
n/a (HTML full text)
npj Breast Cancer (editorial office), 2026-06-05: Editorial Expression of Concern stating that the publisher found multiple highly similar images in Fig. 4d and 4f of the 2021 ivermectin/anti-PD1 paper, that the authors said the original data are no longer available, and that readers should interpret the data with caution. Study type: publisher editorial notice. N: n/a. Country: n/a (Nature Portfolio). Dose/route: n/a. Funder/COI: n/a. This is the current status of the Draganov 2021 checkpoint-synergy paper as of 2026-11-20: an Expression of Concern, not a retraction. The notice says the authors 'have stated that the original data are no longer available' and advises readers 'to interpret these data with caution'. Recorded at full strength against C7. Also filed as IVA-14 (claims C3, C7). Study type: other.
